Becton, Dickinson and Co. | BDX - Despesas Operacionais

Preço das Ações
148.43
Mudança Diária
-1.79 -1.19%
Mensal
-4.05%
Anual
-28.10%
Q2 Previsão
148.88




Despesas Operacionais Alterar Data
Abbott USD 9.31B 104M 2026-03
Agilent USD 1.44B 27M 2025-12
Align Technology USD 822.85M 11.8M 2025-12
AngioDynamics USD 81.95M 1.68M 2025-09
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Boston Scientific USD 4.15B 107M 2026-03
Cooper Companies USD 811.3M 113.5M 2025-12
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 423M 1.06B 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 645.11M 241.46M 2025-12
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Solventum Corp USD 1.89B 3.09B 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Terumo JPY 252.74B 22.88B 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12